Primary |
Epidural Anaesthesia |
17.8% |
Anaesthesia |
11.9% |
Nerve Block |
9.7% |
Local Anaesthesia |
9.3% |
General Anaesthesia |
8.8% |
Spinal Anaesthesia |
7.4% |
Musculoskeletal Pain |
5.2% |
Analgesia |
4.7% |
Postoperative Analgesia |
4.7% |
Maintenance Of Anaesthesia |
2.9% |
Analgesic Therapy |
2.8% |
Pain |
2.2% |
Induction Of Anaesthesia |
2.1% |
Fluid Replacement |
1.7% |
Labour Pain |
1.6% |
Prophylaxis |
1.6% |
Surgery |
1.6% |
Caesarean Section |
1.4% |
Infection Prophylaxis |
1.4% |
Osteoarthritis |
1.4% |
|
Sensory Disturbance |
9.0% |
Renal Failure Acute |
8.3% |
Musculoskeletal Pain |
7.7% |
Overdose |
7.7% |
Anaphylactic Shock |
7.1% |
Muscular Weakness |
6.4% |
Cauda Equina Syndrome |
5.8% |
Grand Mal Convulsion |
4.5% |
Neurotoxicity |
4.5% |
Paraplegia |
4.5% |
Sensorimotor Disorder |
4.5% |
Adverse Drug Reaction |
3.8% |
Convulsion |
3.8% |
Death |
3.8% |
Drug Effect Decreased |
3.8% |
Paralysis |
3.8% |
Movement Disorder |
3.2% |
Circulatory Collapse |
2.6% |
Diplegia |
2.6% |
Drug Ineffective |
2.6% |
|
Secondary |
Drug Use For Unknown Indication |
13.3% |
Epidural Anaesthesia |
12.0% |
Anaesthesia |
11.1% |
General Anaesthesia |
9.2% |
Product Used For Unknown Indication |
9.0% |
Pain |
7.8% |
Premedication |
7.0% |
Analgesia |
4.4% |
Local Anaesthesia |
3.4% |
Postoperative Analgesia |
2.8% |
Preoperative Care |
2.6% |
Nerve Block |
2.5% |
Spinal Anaesthesia |
2.5% |
Caesarean Section |
2.3% |
Musculoskeletal Pain |
2.3% |
Analgesic Therapy |
1.9% |
Back Pain |
1.5% |
Epidural Test Dose |
1.5% |
Neuromuscular Blocking Therapy |
1.5% |
Prophylaxis |
1.5% |
|
Renal Failure Acute |
16.1% |
Sensorimotor Disorder |
9.2% |
Staphylococcal Infection |
9.2% |
Paraplegia |
8.6% |
Grand Mal Convulsion |
5.2% |
Sensory Disturbance |
4.6% |
Axonal Neuropathy |
4.0% |
Cauda Equina Syndrome |
4.0% |
Muscular Weakness |
4.0% |
Neuropathy Peripheral |
4.0% |
Anaphylactic Shock |
3.4% |
Delayed Recovery From Anaesthesia |
3.4% |
Nerve Injury |
3.4% |
Rotator Cuff Syndrome |
3.4% |
Somnolence |
3.4% |
Dyspnoea |
2.9% |
Intervertebral Disc Protrusion |
2.9% |
Musculoskeletal Pain |
2.9% |
Shock |
2.9% |
Convulsion |
2.3% |
|
Concomitant |
Pain |
9.9% |
Surgery |
8.2% |
Nausea |
7.9% |
Hypertension |
7.3% |
Wound Complication |
6.5% |
Anaesthesia |
5.9% |
Thrombosis Prophylaxis |
5.9% |
Constipation |
5.6% |
Sedation |
5.1% |
Insomnia |
4.5% |
Antibiotic Prophylaxis |
4.2% |
Fluid Replacement |
3.7% |
Analgesic Therapy |
3.4% |
Convulsion Prophylaxis |
3.4% |
Infection |
3.4% |
Rectal Cancer |
3.4% |
Cerebral Infarction |
3.1% |
Drug Use For Unknown Indication |
3.1% |
Induction Of Anaesthesia |
3.1% |
Blood Pressure Management |
2.3% |
|
Death |
11.5% |
Arrhythmia |
9.6% |
Wound Secretion |
7.7% |
Deep Vein Thrombosis |
5.8% |
Sepsis |
5.8% |
Stevens-johnson Syndrome |
5.8% |
Tachycardia |
5.8% |
Vasculitis |
5.8% |
Vomiting |
5.8% |
Wheezing |
5.8% |
Altered State Of Consciousness |
3.8% |
Coagulation Factor Increased |
3.8% |
Delayed Recovery From Anaesthesia |
3.8% |
Off Label Use |
3.8% |
Thrombophlebitis Superficial |
3.8% |
Visual Acuity Reduced |
3.8% |
Amnesia |
1.9% |
Anaphylactic Shock |
1.9% |
Concomitant Disease Progression |
1.9% |
Delirium |
1.9% |
|
Interacting |
Thoracic Vertebral Fracture |
30.8% |
Atrial Fibrillation |
23.1% |
General Anaesthesia |
15.4% |
Hypertension |
15.4% |
Anaesthesia |
7.7% |
Induction Of Anaesthesia |
7.7% |
|
Cardiac Disorder |
50.0% |
Drug Interaction |
50.0% |
|